- Home
- BRIA vs MRSN Comparison
BRIA vs MRSN Comparison
Compare BRIA & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- MRSN
- Stock Information
- Founded
- BRIA 2011
- MRSN 2001
- Country
- BRIA Singapore
- MRSN United States
- Employees
- BRIA N/A
- MRSN N/A
- Industry
- BRIA
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- BRIA
- MRSN Health Care
- Exchange
- BRIA NYSE
- MRSN Nasdaq
- Market Cap
- BRIA 47.1M
- MRSN 40.7M
- IPO Year
- BRIA 2024
- MRSN 2017
- Fundamental
- Price
- BRIA $2.47
- MRSN $0.36
- Analyst Decision
- BRIA
- MRSN Strong Buy
- Analyst Count
- BRIA 0
- MRSN 5
- Target Price
- BRIA N/A
- MRSN $5.75
- AVG Volume (30 Days)
- BRIA 8.7K
- MRSN 2.3M
- Earning Date
- BRIA 08-15-2025
- MRSN 08-12-2025
- Dividend Yield
- BRIA N/A
- MRSN N/A
- EPS Growth
- BRIA N/A
- MRSN N/A
- EPS
- BRIA 92.24
- MRSN N/A
- Revenue
- BRIA $59,695,825.00
- MRSN $34,006,000.00
- Revenue This Year
- BRIA N/A
- MRSN N/A
- Revenue Next Year
- BRIA N/A
- MRSN $1.30
- P/E Ratio
- BRIA $0.03
- MRSN N/A
- Revenue Growth
- BRIA 8.03
- MRSN N/A
- 52 Week Low
- BRIA $1.78
- MRSN $0.26
- 52 Week High
- BRIA $4.38
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- MRSN 46.82
- Support Level
- BRIA N/A
- MRSN $0.35
- Resistance Level
- BRIA N/A
- MRSN $0.39
- Average True Range (ATR)
- BRIA 0.00
- MRSN 0.03
- MACD
- BRIA 0.00
- MRSN -0.00
- Stochastic Oscillator
- BRIA 0.00
- MRSN 12.30
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.